Annual ROE
-65.78%
-1.50%-2.33%
31 December 2021
Summary:
Concert Pharmaceuticals annual return on equity is currently -65.78%, with the most recent change of -1.50% (-2.33%) on 31 December 2021. During the last 3 years, it has fallen by -1.50% (-2.33%).CNCE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-115.03%
+0.19%+0.16%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly return on equity is currently -115.03%, with the most recent change of +0.19% (+0.16%) on 30 September 2022.CNCE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -2.3% | -106.4% |
| 5 y5 years | -113.8% | -121.5% |
CNCE ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -197.0% | -197.6% |
Concert Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | -115.03%(-0.2%) |
| June 2022 | - | -115.22%(+27.1%) |
| Mar 2022 | - | -90.63%(+31.2%) |
| Dec 2021 | -65.78%(+2.3%) | -69.09%(+24.0%) |
| Sept 2021 | - | -55.72%(+21.8%) |
| June 2021 | - | -45.74%(-20.2%) |
| Mar 2021 | - | -57.29%(+1.0%) |
| Dec 2020 | -64.28%(+10.7%) | -56.72%(+0.8%) |
| Sept 2020 | - | -56.29%(+3.3%) |
| June 2020 | - | -54.47%(-6.6%) |
| Mar 2020 | - | -58.31%(+0.3%) |
| Dec 2019 | -58.07%(+88.7%) | -58.16%(+12.0%) |
| Sept 2019 | - | -51.92%(+10.4%) |
| June 2019 | - | -47.02%(+17.1%) |
| Mar 2019 | - | -40.15%(+37.7%) |
| Dec 2018 | -30.77%(-145.4%) | -29.16%(+39.8%) |
| Sept 2018 | - | -20.86%(-134.7%) |
| June 2018 | - | 60.07%(-14.7%) |
| Mar 2018 | - | 70.42%(-9.1%) |
| Dec 2017 | 67.82% | 77.47%(-10.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2017 | - | 86.71%(-248.9%) |
| June 2017 | - | -58.22%(+11.7%) |
| Mar 2017 | - | -52.13%(+10.4%) |
| Dec 2016 | -46.91%(-279.9%) | -47.24%(+44.2%) |
| Sept 2016 | - | -32.75%(+15.4%) |
| June 2016 | - | -28.39%(-278.7%) |
| Mar 2016 | - | 15.89%(-28.6%) |
| Dec 2015 | 26.07%(-145.1%) | 22.24%(+45.4%) |
| Sept 2015 | - | 15.30%(-16.6%) |
| June 2015 | - | 18.34%(-138.9%) |
| Mar 2015 | - | -47.11%(-54.6%) |
| Dec 2014 | -57.82%(-1170.7%) | -103.85%(-24.6%) |
| Sept 2014 | - | -137.76%(-49.4%) |
| June 2014 | - | -272.19%(-331.0%) |
| Mar 2014 | - | 117.84%(+929.2%) |
| Dec 2013 | 5.40%(-71.8%) | 11.45%(-27.3%) |
| Sept 2013 | - | 15.74%(+2086.1%) |
| June 2013 | - | 0.72%(-91.9%) |
| Mar 2013 | - | 8.94%(+23.0%) |
| Dec 2012 | 19.16%(+46.8%) | 7.27% |
| Dec 2011 | 13.05% | - |
FAQ
- What is Concert Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual return on equity?
The current annual ROE of CNCE is -65.78%
What is the all time high annual ROE for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual return on equity is 67.82%
What is Concert Pharmaceuticals quarterly return on equity?
The current quarterly ROE of CNCE is -115.03%
What is the all time high quarterly ROE for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly return on equity is 117.84%